摘要
目的分析脑梗死后继发癫痫患者实施托吡酯与卡马西平治疗的疗效。方法 2013年11月-2015年12月我院将94例脑梗死后继发癫痫患者通过电脑随机分组的方式,分为治疗组和常规组,每组患者均为47例。常规组采用卡马西平治疗,而治疗组给予托吡酯治疗。对比分析两组患者的治疗效果。结果采取不同方式后,治疗组患者总有效率为91.49%(43/47);常规组患者总有效率为76.60%(36/47)。治疗组优于常规组(P〈0.05)差异具有统计学意义。结论针对于脑梗死后继发癫痫患者来讲,在对其进行治疗的过程中,运用托吡酯效果优于卡马西平,可对患者的症状起到良好的改善作用。
Objective To analyze the effect of topiramate and carbamazepine in patients with secondary epilepsy after cerebral infarction. Methods From November 2013 to December 2015,94 patients with secondary epilepsy after cerebral infarction were randomly divided into treatment group and control group,47 cases in each group. The conventional group received the carbamazepine treatment,while the treatment group received topiramate treatment. The therapeutic effect of the two groups were compared and analyzed. Results In different ways,the total effective rate was 91.49%(43/47)in the treatment group,and the total effective rate was 76.60%(36/47)in the conventional group. The treatment group was significantly better than the conventional group(P〈0.05),the difference was significant. Conclusion In terms of epilepsy secondary to cerebral infarction patients,in the treatment process,using topiramate effect is better than that of carbamazepine,a good effect on the patient's symptoms,clinical worth promoting the use.
出处
《中国卫生标准管理》
2016年第5期119-120,共2页
China Health Standard Management
关键词
脑梗死后继发癫痫
托吡酯
卡马西平
效果分析
Epilepsy secondary to cerebral infarction
Topiramate
carbamazepine
Effect analysis